Evidence map›Paper›PMID 39997620›Full record

ArticlePediatric reports2025

Intrathymic Hemagioma: A Challenging Case Report with Special Focus on the Importance of Its Multidisciplinary Approach.

Milan Velimirovici, Anca Voichita Popoiu, Simona Cerbu, Calin Marius Popoiu, Florica Ramona Dorobantu, Borislav Dusan Caplar, Eugen Melnic, Anca Maria Cimpean, Larisa Cristina Tomescu, Maria Corina Stanciulescu

Abstract readCase Reports
In one paragraph

Article in Pediatric reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Milan VelimiroviciDoctoral School in Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Anca Voichita PopoiuEmergency Hospital for Children Louis Turcanu, 300041 Timisoara, Romania.
Simona CerbuCenter of Expertise for Rare Vascular Disease in Children, Louis Turcanu Children Hospital, 300041 Timisoara, Romania.
Calin Marius PopoiuCenter of Expertise for Rare Vascular Disease in Children, Louis Turcanu Children Hospital, 300041 Timisoara, Romania.
Florica Ramona DorobantuDepartment of Neonatology, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.ORCID 0000-0001-7036-6030
Borislav Dusan CaplarDoctoral School in Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Eugen MelnicDepartment of Pathology, Victor Babes University of Medicine and Pharmacy, 2004 Chișinău, Moldova.
Anca Maria CimpeanCenter of Expertise for Rare Vascular Disease in Children, Louis Turcanu Children Hospital, 300041 Timisoara, Romania.ORCID 0000-0002-9530-022X
Larisa Cristina TomescuDoctoral School in Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0000-0002-9726-5341
Maria Corina StanciulescuCenter of Expertise for Rare Vascular Disease in Children, Louis Turcanu Children Hospital, 300041 Timisoara, Romania.ORCID 0000-0002-6784-0165

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mediastinal hemangiomas, particularly those of thymic origin, are rare phenomena. Due to its rarity, this pathologic condition is not characterized as related to the angiogenic profile of hemangioma endothelial cells. The diagnosis is challenging clinically and radiologically, and biopsies may not yield a definitive answer. Surgical resection offers the material for histologic diagnosis, relieves symptoms, and has a favorable long-term prognosis for such benign tumors. Sometimes, such benign tumors may have aggressive behavior and repeated recurrences but the causes responsible for this unpredictable evolution are not actually known. A case of intrathymic hemangioma diagnosed in a 16-year-old girl is presented here. We focused equally on a multidisciplinary approach to this challenging diagnosis but also on the characterization of the hemangioma endothelial cells profile not previously performed for such type of vascular anomalies. To define an antibodies panel for the evaluation of intrathymic hemangiomas may help in the full characterization of this rare vascular lesion, and subsequently focus on the new therapeutic targets which may be applied for cases with aggressive behavior.

Indexed as

endothelial cellsintrathymic hemangiomathymic vascular tumor

Identifiers

PMID39997620
PMCPMC11857899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.